Miguel Gómez Fontela
Lab Information
Centro Nacional de Microbiología, Instituto de Salud Carlos III
Research Area and Skills
Recognize this scientist’s Expertise for their contribution in your research
CRISPR-Cas9 0 immunology 0 genetics 0 transcriptional regulation 0 molecular biosciences 0 cell culture 0 western blot 0 CRISPR-interference 0 CRISPR-activation 0 nucleic acid purification 0 mouse models 0 chromatin immunoprecipitation 0 enChIP 0 LIFT 0 PCR 0
- Post
- Publication
- Plasmid
- Following (0)
- Follower (2)
Cytotoxic T lymphocytes (CTLs) are cells that belongs to the adaptive immune system which eliminate tumorigenic or pathogen-infected cells. The process by which CTLs recognize the cognate antigens presented by target cells to eliminate them is called immunosurveillance. As target ...Learn More
- Like (6)
- Reply
-
Share
Although titanic efforts are being made for the development of treatments against the novel SARS-CoV-2 disease (COVID-19) and the approval of the recently developed vaccines by the Food and Drug Administration (FDA) and counterpart regulatory agencies such as the European ...Learn More
Coronaviruses (CoVs) are enveloped, single-stranded, positive-sense RNA viruses belonging to the Nidovirales order and responsible for causing seasonal mild respiratory illness in humans [1], although severe acute respiratory syndrome CoV (SARS-CoV) in 2002 and Middle East ...Learn More
Cancer appears from the own cells of an organism and creates a tumor microenvironment with immune evasion and immunosuppression signals capable of avoiding the immune response [1]. Immunotherapy is a medical strategy applied to the treatment of cancer based on harnessing the ...Learn More
Understanding the nature of the immune response that leads to recovery over severe disease is key to developing effective treatments for COVID-19. Coronaviruses typically induce strong inflammatory responses and associated lymphopenia [1, 2], and it has been reported that during ...Learn More
Author: Fontela, M. G et al. ‘The Core Region of the Conserved Non-Coding Sequence 2 Enhancer Function as a Switch for Human CD69 Transcription and Its Controled Cytokine Production'. Under review.
Redondo, J., Fontela, M. G et al. ‘Functional characterization of a dual enhancer/promoter regulatory element leading human CD69 expression'. Frontiers in Genetics. Accepted 8th October 2020.
Coauthor: Lorente, E., Fontela, M. G et al. ‘Modulation of natural HLA-B*27:05 ligandome by ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 2 (ERAP2)'. Molecular & Cellular Proteomics, 2020, 19 (6) 994-1004. doi:10.1074/mcp.ra120.002014
Coauthor: A. Márquez and Miguel G. Fontela. 'Fluorescence enhanced BA-LIFT for single cell detection and isolation'. Biofabrication. January 2020. DOI: 10.1088/1758-5090/ab6138
Author: Miguel G. Fontela et al. ‘The Conserved Non-Coding Sequence 2 (CNS2) Enhances CD69 Transcription Trough Cooperation Between the Transcription Factors Oct1 and RUNX1'. Genes. August 2019. DOI: 10.3390/genes10090651
Collaborator: David Canteli et al. ‘Laser-Induced Forward Transfer of silver-based pastes for metallization of photovoltaic devices. SPIE conference proceedings. DOI: https://doi.org/10.1117/12.2508975
Collaborator: Laguna. T et al. ‘New insights on the transcriptional regulation of CD69 gene through a potent enhancer located in the conserved non coding sequence 2'. Molecular Immunology. March 2015. DOI:10.1016/j.molimm.2015.02.031
This guy hasn’t plasmids anything yet.
Hot plasmids
This guy has no following anyone.
Popular Cloud Scientists
About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2020 MolecularCloud